References
Snoeck R, Andrei G, Gerard M, et al. Successful treatment of progressive mucocutaneous infection due to acyclovir and foscarnet-resistant herpes simplex virus with (s)-l-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (HPMPC). Clin Inf Dis 1994; 18: 570–8
Rooney JF, Straus SE, Mannix ML, et al. Oral acyclovir to suppress frequently recurrent herpes labialis. Ann Intern Med 1993; 118(4): 268–72
Whitley R, Lakeman F. Herpes simplex virus infections of the central nervous system: therapeutic and diagnostic considerations. Clin Inf Dis 1995; 20: 414–20
Whitley R, Arvin A. Herpes simplex virus infections. In: Klein JR, Klein J, editors. Infectious diseases of the fetus and newborn infant. Philadelphia (PA): Saunders, 1995: 354–76
Kesson AM. Management of neonatal herpes simplex virus infection. Paediatr Drugs 2001; 3(2): 81–90
American Academy of Pediatrics. Herpes Simplex. In: Pickering LK, ed 2000 Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2000: 309–18
Whitley R, Arvin A, Prober C, et al. Predictors of morbidity and mortality in neonates with herpes simplex virus infections. N Engl J Med 1991; 324: 450–4
Kimberlin DW, Lin CY, Jacobs RF et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics 2001; 108(2): 230–8
Kimberlin DW, Lin CY, Jacobs RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics 2001; 108(2): 223–9
Scott LL, Sanchez PJ, Jackson GL, et al. Acyclovir suppression to prevent caesarean delivery after first-episode genital herpes. Obstet Gynecol 1996; 87(1): 69–73
Brocklehurst P, Kinghorn G, Carney O, et al. A randomised placebo controlled trial of suppressive acyclovir in late pregnancy in women with recurrent genital herpes infection. Br J Obstet Gynaecol 1998; 105: 275–80
Hutto C, Arvin A, Jacobs R, et al. Intrauterine herpes simplex virus infections. J Pediatr 1987; 110: 97–101
Whitley R, Arvin A, Prober C, et al. A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med 1991; 324: 444–9
Whitley R, Yeager A, Kartus P, et al. Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics 1983; 72: 778–85
Kimberlin D, Powell D, Gruber W, et al. Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial. Pediatr Infect Dis J 1996; 15: 247–54
Rights and permissions
About this article
Cite this article
The prognosis for many infants with neonatal herpes simplex virus infection remains poor. Drugs Ther. Perspect 17, 5–8 (2001). https://doi.org/10.2165/00042310-200117230-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200117230-00002